Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines  by Schmidt-Ioanas, Malina et al.
ARTICLE IN PRESSRespiratory Medicine (2006) 100, 639–647KEYWORD
COPD;
Exacerbati
Apoptosis;
Cytokines
0954-6111/$ - s
doi:10.1016/j.r
Correspondi
E-mail addr
1Authors conApoptosis of peripheral blood neutrophils in COPD
exacerbation does not correlate with serum
cytokines
Malina Schmidt-Ioanasa,,1, Mathias W.R. Pletzb,1,
Andres de Rouxa, Hartmut LodeaaDepartment of Chest and Infectious Diseases, Helios Klinikum Emil von Behring, Zum Heckeshorn 33,
14109 Berlin, Germany
bDepartment of Pulmonology, Medizinische Hochschule Hannover, Germany
Received 3 June 2005; accepted 2 August 2005S
on;
ee front matter & 2005
med.2005.08.011
ng author. Tel.: +49 30
ess: imalina@yahoo.com
tributed equally to thisSummary The study investigated the relationship between apoptosis of peripheral
blood neutrophils during exacerbation of chronic obstructive pulmonary disease
(COPD) and the inflammatory response that characterises this condition. Twenty-six
hospitalised patients with COPD exacerbation and 13 controls were included. Three
sequential blood and sputum samples were obtained from patients at admission,
after 3 days and at discharge. Blood apoptotic neutrophils were measured by flow-
cytometry and light microscopy. Serum and sputum levels of IL-6, IL-8 and TNF-a
were determined by an immunoassay technique. We found a significantly reduced
percentage of apoptotic neutrophils at the onset of COPD exacerbation which
increased over time (1.170.4% at admission vs. 2.470.4% at discharge, Po0:0001).
Patients presented no changes in serum cytokines neither during exacerbation nor in
comparison to controls. In contrast, sputum levels of cytokines were significantly
increased compared to serum levels. There was no significant correlation between
the apoptotic neutrophils and the cytokine concentrations in serum or sputum. None
of the clinical parameters, such as smoking, microbial infection, corticosteroids or
hypoxemia showed a correlation with neutrophil apoptosis. No relationship could be
found between the reduced percentage of apoptotic neutrophils in blood and serum
concentration of IL-6, IL-8 and TNF-a or other clinical parameters in patients with
COPD exacerbation.
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Exacerbations are typical events in patients with
chronic obstructive pulmonary disease (COPD) and
have been associated with an increased inflamma-
tory response that contributes to continuous tissue
damage and progressive bronchial obstruction.1–3
Neutrophils are key cells in the COPD-associated
inflammatory processes. Patients with COPD exhibit
enhanced activity in circulating neutrophils4 and a
massive accumulation of neutrophils in the bron-
chial tree.5 The increased number of neutrophils
found in sputum and bronchoalveolar lavage may
be the result of an intense neutrophil migration
from the blood vessels due to chemotactic factors
and/or a consequence of a prolonged survival due
to anti-apoptotic factors.6 The apoptotic process
facilitates the removal of inflammatory cells and is
essential for the termination of inflammation. An
impaired apoptotic mechanism presumably contri-
butes to the accumulation of the neutrophils and
the development of a persistent inflammatory
condition.7
Little evidence exists concerning the particula-
rities and the regulation of the circulating neutro-
phil apoptosis in COPD, a pulmonary disease which
has been shown by several investigations to have a
clear systemic involvement.8 A recent study on
neutrophil apoptosis in patients with community-
acquired pneumonia showed that patients with
underlying COPD present a significantly reduced
proportion of apoptotic blood neutrophils in com-
parison to patients without comorbidities.9 No-
guera et al.10 found that COPD patients in stable
state have similar percentage of apoptosis in blood
neutrophils in comparison to healthy controls but
exhibit an increased expression of adhesion mole-
cules on the surface of the apoptotic neutrophils
indicating a previously higher level of activation. In
a previous study, we investigated patients with
COPD exacerbation and found a delayed apoptosis
of peripheral blood neutrophils ex vivo at the onset
of the exacerbation.11 Apoptosis recovered after 14
days, paralleling the clinical improvement and no
differences were observed between COPD patients
at discharge and the healthy controls, similar to the
study of Noguera et al.
Based on these findings, we hypothesised that
the distinctive pattern of apoptosis of the periph-
eral blood neutrophils in these patients is related
to the increased inflammatory response that
characterises COPD exacerbations. According to in
vitro studies, some key cytokines involved in the
local and systemic inflammation during exacerba-
tion, such as IL-6, IL-8 and TNF-a, are also
associated with the regulation of apoptosis.12–14The present study aimed to investigate the
relationship between apoptosis of peripheral blood
neutrophils and the cytokines IL-6, IL-8 and TNF-a
in patients with COPD exacerbation.Material and methods
Patients
Twenty-six hospitalised patients with a documented
diagnosis of COPD according to GOLD criteria1 and
presenting an exacerbation were included. The
exacerbation was defined by any combination of
the following major criteria: worsening dyspnoea,
increase in sputum volume, and increase in sputum
purulence; additional minor criteria (upper respira-
tory tract infection in the last 5 days, fever,
increased wheezing, increased cough) were also
taken into account, as described elsewhere.15
Patients with new radiological pulmonary infiltrate,
known HIV infection, immunosuppressive therapy
(other than corticosteroids), evidence of bronch-
iectasis or tumour were excluded.
In all patients, treatment of COPD exacerbation
consisted of inhaled bronchodilators, systemic
corticosteroids (prednisolone 75mg i.v. daily for 3
days, followed by oral therapy 1mg/kg for 2
weeks), antibiotics (beta-lactams or fluoroquino-
lones), and oxygen if PO2o60mmHg.
A group of healthy controls were also investi-
gated. It has been suggested that aging is asso-
ciated with changes in neutrophil apoptosis16;
therefore we recruited only controls older than
60, in order to match the COPD group. Exclusion
criteria for the control group were: fever or
antibiotic prescription during the previous month,
smoking, any chronic pulmonary, hepatic, cardio-
vascular, neurological, rheumatologic or renal
condition, diabetes mellitus, immunosuppressive
therapy (including current systemic corticosteroid
treatment with 415mg/day in the previous 3
weeks), known HIV infection, evidence of tumour
at any site.
The study was approved by the local ethical
committee and written informed consent was
obtained from all patients and controls prior to
enrolment.
Design
A prospective study was conducted over a period of
8 months. All patients were investigated at admis-
sion (before initiating any treatment), after 3 days
and after 14 days. Blood and sputum samples were
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were recorded on admission: age, sex, weight,
height, smoking habits, previous medication, signs
and symptoms of respiratory infection, chest radio-
graph (to exclude pulmonary infiltrates), lung
function tests, blood gases analysis and microbio-
logical findings.
The controls were investigated once, at inclusion
in the study, for neutrophil apoptosis and serum
concentrations of cytokines.
Measurement of apoptotic neutrophils
Two methods have been used for measuring
apoptosis: (1) flow cytometric measurement of
Annexin V-PE/7AAD stained cells and (2) light
microscopy to assess the nuclear morphology.
Separation of neutrophils from peripheral blood
The isolation of neutrophils from peripheral blood
was performed as described previously.11 Briefly,
neutrophils were separated by density gradient
centrifugation at 470g for 25min using Ficoll
separating solution (Biochrom KG Berlin, Germany)
followed by hypotonic lysis of erythrocytes. The cell
suspension was washed and resuspended at a
concentration of 1 106 cells/ml in RPMI medium
supplemented with 5.9 g HEPES, 2 g NaHCO3, 50ml
FCS, 20ml Penicillin-Streptomycin-Neomycin 2% so-
lution, pH ¼ 7.4. Only cell suspensions with 496%
neutrophils and a viability of495% as determined by
trypan blue (Sigma, Taufkirchen, Germany) staining
were considered for further analyses.
Annexin V-PE/7AAD staining and flow cytometry
This technique is based on the property of
apoptotic cells to early redistribute the phosphati-
dylserine (PS) from the inner to the outer layer of
cell membrane. As described elsewhere,11 during
early stages of apoptotis a cell will stain with
Annexin V, which has selective affinity for PS, but
not with 7-amino-actinomycin D (7AAD), which
stains the nucleus of cells with ruptured mem-
branes.
Annexin V-PE/7AAD staining was performed with
the Annexin V-PE Apoptosis Detection Kit I (Phar-
Mingen, Becton Dickinson, Heidelberg, Germany)
according to manufacturer’s protocol. Briefly, the
isolated neutrophils were washed and centrifuged
in binding buffer (0.1M HEPES/NaOH (pH 7.4),
1.4M NaCl, 25mM CaCl2) and the pellet was
resuspended in 5 ml Annexin V-PE, 5 ml 7AAD and
100 ml binding buffer, followed by incubation for
15min at room temperature and in the dark.
Measurement was performed within 15min bya three-colour flow-cytometer (FACScan Becton-
Dickinson, Heidelberg, Germany) using CellQuest
software. A predetermined count of 10,000 granu-
locytes was set on forward light scatter. Annexin V-
PE was read in FL-2 and 7AAD in FL-3. Only Annexin
V-PE (+) cells with intact cell membrane, i.e. 7AAD
(), were considered as apoptotic and expressed as
percentage of the total neutrophil count.Nucleus morphology and light microscopy
Another assessable feature of apoptotic cells is the
condensation and fragmentation of chromatin that
can be observed by light microscopy. A cytospin
slide was prepared from the RPMI-suspended
neutrophils (2 100ml centrifuged at 470g for
3min) and stained with Pappenheim solution
(Sigma, Taufkirchen, Germany). Two hundred cells
were counted and morphologically evaluated by
light microscopy. Apoptotic neutrophils were iden-
tified by a condensed single-lobed or a completely
fragmented nucleus, and were expressed as per-
centage of the total neutrophil count.Measurement of IL-6, IL-8, TNF-a in serum
and sputum
Blood samples were centrifuged at 1400g for
10min; the serum was aliquoted and stored at
70 1C until measurement.
Spontaneous sputum samples were collected
from COPD patients in a sterile pot after rinsing
the mouth with water. A sputum smear for Gram’s
stain was prepared and neutrophils and squamous
cells were counted under low-power microscopy
( 100) and samples with 425 neutrophils and
o10 squamous cells per field were considered valid
for further microbial and cytokine investigation.
The weight of the sample was recorded. The
sputum was then mixed with equal volume of
dithiothreitol (Sputolysins Reagent, Calbiochem,
Merck Biosciences GmbH, Schwalbach, Germany),
diluted 1:10 in NaCl 0.9% and placed in a shaking
water bath at 37 1C for 15min, during which the
sample was further homogenised every 5min. After
filtering through gauze to remove mucus and debris
and centrifugation at 470g for 10min, the super-
natant was aliquoted and stored at 70 1C until
measurements.
IL-6, IL-8 and TNF-a in serum and sputum were
measured by a solid phase Enzyme Amplified
Sensitivity Immunoassay (BioSource Europe SA, IBL
Hamburg, Germany) and expressed in pg/ml. The
minimum detectable concentrations were 2 pg/ml
for IL-6, 0.7 pg/ml for IL-8 and 3 pg/ml for TNF-a.
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tion of IL-8 and at 1:4 for detection of TNF-a.Statistical analysis
Data processing and analysis were performed using
SPSS 10.0 for Windows (SPSS, Chicago, IL, USA).
Normally distributed data are expressed as percen-
tage and mean7SD, categorical data as percentage
and non-normally distributed data as median and
interquartile range. The parametric distribution
was confirmed by the Shapiro-Wilk test. Apoptotic
neutrophils at each measurement were contrasted
using paired t-test. Cytokines levels at each
measurement were compared using Wilcoxon test.
The correlation between the two methods of
measurement and the correlation between apopto-
tic neutrophils and cytokines level (all time-points)
were evaluated by Spearman’s coefficient. The
comparison of apoptosis percentages and cytokine
levels between patient groups, categorised accord-
ing to clinical parameters, was performed by the
unpaired t-test and Anova test with post-hoc
Bonferroni correction. A P value of o0.05 was
considered as significant.Results
Baseline characteristics
Twenty-six patients with COPD exacerbation were
included in the study. The baseline characteristics
are shown in Table 1. The control group consisted ofTable 1 Baseline characteristics of patients with COPD
n
Age, years (mean7SD)
Male/female, n
Smoker/ex-smoker, n
BMI, mean7SD
Corticosteroid therapy prior to hospital admission
Oral, n (%)
Inhaled, n (%)
None, n (%)
FEV1 on admission, % of predicted value, mean7SD
PO2 on admission, mmHg, mean7SD
Microbial growth in sputum
Yes, n (%)
No, n (%)
Non-valid sample, n (%)
SD: standard deviation; BMI: body mass index (weight (kg)/height
pressure of oxygen.13 subjects (mean age 67.973.3 years; seven men
and six women).
Levels of apoptotic neutrophils in peripheral
blood
In contrast to changes in core morphology due to
chromatin condensation and fragmentation, the
externalisation of phophatidylserine (measured by
using the binding protein Annexin V) is an early
feature of apoptosis. Therefore, the apoptotic
rates measured by Annexin V-PE/7AAD staining
were discretely higher than those observed by core
morphology evaluation (data not shown). However,
the two methods used for the measurement of
neutrophil apoptosis showed a good correlation
(r ¼ 0.747, P ¼ 0:001, all time-points) and the
values provided by flow-cytometry have been
further considered in the statistical analysis.
Figure 1 shows the mean percentage of apoptotic
neutrophils in patients with COPD exacerbation and
in controls. There was a statistically significant
difference between the percentage of apoptotic
neutrophils at admission vs. day 3 (1.170.4% vs.
1.970.8%, P ¼ 0:01) as well as at admission vs. day
14 (1.170.4% vs. 2.470.8%, Po0:0001) in COPD
patients. Furthermore, COPD patients presented a
significantly lower apoptosis percentage at admis-
sion compared to controls (1.170.4% vs.
2.170.3%, Po0:0001), while the values of day 14
were similar to those of controls (P ¼ 0:1).
Serum and sputum levels of cytokines
Figure 2 shows the levels of IL-6, IL-8 and TNF-a in
serum of controls and COPD patients. No increase inexacerbation.
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Figure 1 Mean apoptosis percentage of peripheral blood
neutrophils measured by flow-cytometry in patients with
COPD exacerbation and in controls; Po0:0001 (COPD
patients at admission vs. controls); P ¼ 0:01 (day 3 vs.
admission); yPo0:0001 (day 14 vs. admission).
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onset of COPD exacerbation when compared to the
values provided by the control group (median,
expressed in pg/ml): IL-6 13.4 vs. 11.3, P ¼ 0:9; IL-
8 3.6 vs. 0.8, P ¼ 0:1; TNF-a 11.1 vs. 14.2, P ¼ 0:2.
Furthermore, there was no significant change in
serum level of cytokines during the course of
exacerbation. When stratifying the COPD patients
according the corticosteroid treatment prior to
hospitalisation, no differences were observed be-
tween the groups with oral, inhaled or naı¨ve
steroids with respect to serum IL-6 (P ¼ 0:8), IL-8
(P ¼ 0:3) and TNF-a (P ¼ 0:8).
In contrast, increased levels of cytokines were
observed in sputum of COPD patients at the onset
of the COPD exacerbation (Table 2) in comparison
to their serum levels: IL-6 837 vs. 13.4, P ¼ 0:001;
IL-8 11, 755 vs. 3.6, P ¼ 0:001; TNF-a 134 vs. 11.1,
P ¼ 0:002. Because the expectoration improved
after treatment in more than 70% of patients, no
accurate statistical comparison of sputum levels
between admission and day 14 was possible.Correlation of apoptotic neutrophils with
sputum and serum cytokines
We tried to correlate the percentage of apoptotic
neutrophils to the level of serum cytokines,assuming that a small, undetectable increase of
these proinflammatory cytokines may result in a
marked reduction of apoptosis at the onset of
exacerbation. Only IL-6 presented a discrete
negative correlation with apoptotic neutrophils
(r ¼ 0.237, P ¼ 0:032) while no correlation could
be observed between apoptotic neutrophils and
serum IL-8 and TNF-a (Table 3).
We also tested for a possible relationship
between the percentage of apoptotic neutrophils
and the sputum concentration of the measured
cytokines but no significant correlation could be
observed.
Correlation of neutrophils apoptosis with
clinical parameters
Patients were categorised according to recorded
clinical parameters which could possibly have an
impact on neutrophil apoptosis. No differences in
the level of apoptotic neutrophils at admission
were found in respect to the severity of bronchial
obstruction (FEV1o35% 1.170.5% vs. FEV1X35%
1.270.1%, P ¼ 0:6), body weight (BMIo20
1.570.7% vs. BMIX20 1.070.3%, P ¼ 0:1), micro-
bial infection (microbial growth in sputum 1.37
0.3% vs. no growth 1.170.5%, P ¼ 0:4), smoking
habits (current smokers 1.470.6% vs. ex-smokers
1.070.4%, P ¼ 0:1), corticosteroid treatment prior
to admission (oral 1.170.7% vs. inhaled 1.270.2%,
P ¼ 0:9; oral 1.170.7% vs. steroid naı¨ve 0.970.3%,
P ¼ 0:3) or hypoxemia (PO2o60mmHg 0.870.3%
vs. PO2X60mmHg 1.270.3%, P ¼ 0:06).Discussion
Our study revealed a reduced percentage of
apoptotic blood neutrophils in patients with
COPD exacerbation. This reduction in apoptotic
neutrophils was not related to serum and sputum
concentrations of IL-6, IL-8 and TNF-a or to other
specific clinical parameters.
In a previous investigation we showed that blood
neutrophils of patients with COPD exacerbation
exhibited a delayed spontaneous apoptosis ex vivo
which was progressively restored after treatment
and clinical remission.11 This finding has been
confirmed by the present study as well as by an
other recent investigation9 and may be a feature of
the non-specific immune response against the
triggers of exacerbation. Blood neutrophils have a
short life span in the circulation (6–12 h) and are
usually removed through genetically programmed
apoptosis. However, the normal survival may be
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Figure 2 The levels of IL-6, IL-8 and TNF-a in serum in patients with COPD exacerbation and in controls. The horizontal
line is the median value; the box is the interquartile range, excluding outlying and extreme values. Neither between
the three sequential measurements nor in comparison to controls statistically significant differences could be detected
for any of measured cytokines.
Table 2 The levels of IL-6, IL-8 and TNF-a in sputum in patients with COPD exacerbation.
Cytokine Admission Day 3 Day 14
(n ¼ 26) (n ¼ 15) (n ¼ 7)
IL-6 837 (193–2266) 643 (525–2136) 47.0 (36.0–385)
IL-8 11,755 (7370–23,900) 10,870 (8305–17,680) 2850 (836–8317)
TNF-a 134 (22.8–538) 14.0 (12.0–14.8) 12.0 (12.0–14.0)
Data given as median value and interquartile range, expressed in pg/ml.
IL-6: interleukin-6; IL-8: interleukin-8; TNF-a: tumor necrosis factor-a.
M. Schmidt-Ioanas et al.644prolonged up to 48 h under certain conditions such
as elevated blood concentration of cytokines,
hormones or glucocorticoids.
Dunican et al.13 showed that TNF-a stimulates
neutrophil apoptosis during the first hours, while
prolonged exposure has an inhibitory effectmediated by the anti-apoptotic chemokine IL-8.
Biffl et al.14 reported that IL-6 also delays neutrophil
apoptosis in vitro. A study focusing on the neutro-
phils apoptosis in patients undergoing coronary
bypass found that apoptosis was suppressed post-
operatively but the apoptotic percentage increased
ARTICLE IN PRESS
Table 3 Correlation between the percentage of
apoptotic neutrophils and serum and sputum levels
of IL-6, IL-8 and TNF-a during COPD exacerbation.
Cytokine r P value
Serum
IL-6 0.237 0.032
IL-8 0.135 0.225
TNF-a 0.127 0.074
Sputum
IL-6 0.115 0.574
IL-8 0.121 0.557
TNF-a 0.146 0.487
IL-6: interleukin-6; IL-8: interleukin-8; TNF-a: tumor
necrosis factor-a; r: Spearman’s bivariate correlation
coefficient.
Apoptosis of peripheral blood neutrophils in COPD exacerbation 645after plasma depletion of IL-6 and IL-8, suggest-
ing an important anti-apoptotic role for these
cytokines.17
An increased systemic inflammatory reaction in
COPD patients has been proposed as an explanation
for systemic hypoxemia18 and weight loss.19
Furthermore, in a study of Wedzicha et al.20 on
67 COPD patients, serum IL-6 was found to be
slightly but significantly increased during exacer-
bation compared to stable state. These results
could not be reproduced by our study. One possible
explanation for this lack of increase in serum
cytokine concentrations could be that we only
enrolled 26 patients. This number of patients
maintained enough statistical power to detect
differences in the proportion of apoptotic neutro-
phils and sputum cytokine concentrations, but it
might have not been sufficient enough to detect
the much more moderate differences in serum
cytokine levels, if they should exist. However, our
study shows clearly that the pronounced decrease
in apoptotic neutrophils at the onset of a COPD
exacerbation cannot be related to IL-6, IL-8 and
TNF-a serum concentration. In fact, an interesting
study of Murray et al.21 shows that LTB4, a
proinflammatory molecule that can be synthesised
and released by neutrophils, induces in vitro a
powerful activation of granulocytes but, contrary
to the current opinion, has little impact on the cell
survival. The authors are suggesting that the
granulocyte activation and the respective granulo-
cyte-released inflammatory agonists do not appear
to be critical for the delay of granulocyte apoptosis
and that these events are not necessary directly
related.
A limitation of our study is that no measurements
of GM-CSF and G-CSF were performed; thesemediators have been associated with an increase
in neutrophils in peripheral blood, nasal and
respiratory secretions during viral exacerbation of
asthma22 and they are also involved in the regula-
tion of neutrophil apoptosis.23
Several studies are reporting important changes
in the inflammatory markers in sputum in COPD
patients during acute exacerbations.24,25 We also
found high levels in sputum cytokines at the onset
of the exacerbation, when compared to serum
level, which decreased during the course of
exacerbation, paralleling the clinical resolution.
However, no correlation could be observed be-
tween the behaviour of measured sputum cytokines
and that of the apoptotic neutrophils in peripheral
blood, suggesting again that the two events are
probably triggered and controlled by different
factors. On the other hand, the measurements of
cytokines in sputum exhibit variability due to
several factors such as the temperature of proces-
sing, the nature of sputum, the effect of dithio-
threitol etc.26 Although during our study the
processing of sputum was uniform, technical
limitations cannot be excluded and should be
considered as a possible reason for these discre-
pancies.
Some other factors may be responsible for the
reduced apoptosis of neutrophils in COPD exacer-
bation. Aoshiba et al.27 reported a strong anti-
apoptotic effect of nicotine on neutrophils in vitro;
however, we found no significant difference be-
tween the percentage of apoptotic neutrophils in
smokers vs. ex-smokers. This may be explained by
the fact that the current smokers in our study
discontinued or reduced smoking within the pre-
vious days because of the exacerbation of their
symptoms, so that nicotine was practically re-
moved from their blood and had no immediate
influence on neutrophil apoptosis by the time of
first measurement. Similarly, a recent study by
Hodge et al.28 found no differences in apoptosis of
airway cells and BAL-derived T-cells between
smokers and non-smokers COPD patients. However,
it has been shown that an impaired neutrophils
gene expression in smokers is maintained for at
least 8 weeks after smoking cessation,29 suggesting
that the effects of smoking on neutrophils are
far more persistent and complex in vivo compared
to in vitro.
Some bacterial products, such as lipopolysac-
charide, have been also shown to prolong the
survival of neutrophils in vitro studies30 and in
animal model,31 through complex mechanisms,
including activation of NF-kappa B and expression
of anti-apoptotic proteins. Taking into account
this evidence, we also analysed the relationship
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tion and the neutrophil apoptotis. No significant
difference in the percentage of apoptotic neutro-
phils was found in our population with regard to
the presence or absence of microbial growth in
sputum, probably because the infection was con-
fined to the airways without massive endotoxemia
or bacteremia.
There is overwhelming in vitro evidence showing
that glucocorticoids attenuate neutrophil apoptosis
and a recent in vivo study in bovine32 reported that
dexamethasone administered to steers resulted in a
statistically significant decrease in Fas mRNA
abundance in blood neutrophils with subsequent
prolonged cell survival. In contrast to this finding,
the percentage of apoptotic neutrophil in COPD
patients in our study constantly increased over time
although all these patients received intravenous
followed by oral steroids. Furthermore, there was
no difference in percentage of apoptotic neutro-
phils at admission between patients on previous
treatment with oral versus inhaled steroids or
steroid naı¨ve. In a similar context, a study on
apoptosis of airway epithelial and T-cells in COPD
patients found that inhaled glucocorticoids did not
significantly influence the survival of these cells,
which was partly explained by the heterogeneity of
the type of drug, dose and compliance to therapy.28
Hypoxia is another factor that may induce the
neutrophil survival through the hypoxia-inducible
factor (HIP1-a) present on the neutrophils.33 The
study of Tamura et al.34 showed that acute
hypoxemia enhances the inflammatory response
and delays the apoptosis of circulating neutrophils.
However, no differences in the apoptotic percen-
tage of neutrophils were observed in our patients
with respect to PO2 levels, maybe because such a
dramatic hypoxemia was not noted in any of them.
In conclusion, we believe that our investigation
showing the impairment of systemic neutrophils
apoptosis in COPD exacerbation provides a novel
finding that supports the concept of COPD as a
systemic disease. The surprising lack of relationship
of this phenomenon with important disease-related
factors, such as cytokines, smoking, obstruction,
hypoxemia or glucocorticoids, raises a number of
questions which deserve future research to clarify
the significance and regulation of this process.Acknowledgements
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